MTA for patients with lung 2 (159), Level IV Retrospective study design in one, High metastases in whom the primary reporting of adverse events was tumour is under control. Patients incomplete for one study, poor included those with primary reporting in relation to consecutive nasopharyngeal carcinoma in one recruitment of patients, study and mixed primary cancers comprehensive eligibility criteria and in another. follow-up. MTA for patients with lung 3 (103), Level III-2 (2 Studies did not allocate patients to High metastases or primary NSCLC studies), Level IV (1 interventions based on a treated with palliative intent. study) randomisation procedure and patient demographics were variably reported. MTA for mixed populations, 15 (977), Level IV Reporting of adverse events was High included for an extended incomplete in k = 5/15. Poor reporting assessment of harms. in relation to consecutive recruitment of patients, comprehensive eligibility criteria and follow-up was an issue. < k = number of studies; MTA = microwave tissue ablation; NSCLC = non-small cell lung cancer >
MTA for patients with lung metastases in whom the primary tumour is under control. Patients included those with primary nasopharyngeal carcinoma in one study and mixed primary cancers in another. 2 (159), Level IV Retrospective study design in one, reporting of adverse events was incomplete for one study, poor reporting in relation to consecutive recruitment of patients, comprehensive eligibility criteria and follow-up. High MTA for patients with lung metastases or primary NSCLC treated with palliative intent. 3 (103), Level III-2 (2 studies), Level IV (1 study) Studies did not allocate patients to interventions based on a randomisation procedure and patient demographics were variably reported. High MTA for mixed populations, included for an extended assessment of harms. 15 (977), Level IV Reporting of adverse events was incomplete in k = 5/15. Poor reporting in relation to consecutive recruitment of patients, comprehensive eligibility criteria and follow-up was an issue. High < k = number of studies; MTA = microwave tissue ablation; NSCLC = non-small cell lung cancer >
1403%20-%20Final%20Contracted%20Assessment%20Report%20(ACCESSIBLE).docx